pseudohypoparathyroidism type la (gene for transducer GNAS1 – guanine nucleotide-binding protein, α-stimulating polypeptide) – AD disease, also includes resistance to TSH;
thyroid hormone resistance (TRβ nuclear receptor gene) – hormone levels may be elevated
due to drugs (lithium, PAD, amiodarone) and strumigens.
Clinical manifestation
fatigue, drowsiness, shivers, a tendency to depression, bradyphrenia;
dry skin on the forearm – Charvat's symptom, myxedema – swelling of the lower leg, face with hypomimia, subsequent involvement of the tongue and vocal cords, which causes a deep voice;
in the elderly, the symptoms are often discrete or absent (oligosymptomatic form).
Diagnosis
In the laboratory, there are lower values of T3 and T4 and higher TSH, or a test with i.v. application of TRH is performed to distinguish the peripheral form from the central one;
The hormone feedback of the thyroid.In autoimmune hypothyroidism, the presence of antibodies (against TSH-receptors, thyroglobulin, thyroid peroxidase) is demonstrated;
Ultrasound examination, which shows a possible change in gland tissue (occurrence of nodules);
Cholesterol and TAG, higher CK, LDH and aminotransferases may be elevated in a laboratory.
In some cases, anemia can occur.
Subclinical hypothyroidism
TSH elevation ;
T3 and T4 are normal (practically almost exclusively free thyroxine is measured – fT4, which is biologically active);
often without clinical symptoms, hormone replacement therapy just in case of clinical symptoms;
it usually turns into a manifest form later.
Treatment
Letrox®
Levothyroxin (Euthyrox®, maintenance dose 100–150 μg/day or Letrox®), a T4 analogue, is substituted. Synthetic T3 analogues are given just in case of insufficient response to levothyroxine treatment. The control of treatment is important – the level of TSH is determined as a parameter to compensate for hypothyroidism. In severe hypothyroidism, minimal doses of levothyroxine are initially given and gradually increased very slowly (otherwise there is a risk of thyrotoxicosis).
It's mostly hypothyroidism that originated as a part of hypopituitarism, dominated by symptoms of hypocorticism, the treatment of which also takes precedence over the correction of hypothyroidism. It manifests itself mainly in fatigue and drowsiness, lacking myxedema and usually goitre, TSH is not increased (usually its level is normal), the main feature is a decrease in fT4 and other signs of hypopituitarism, it's necessary to examine the hypothalamic-pituitary region by imaging methods (CT, NMR). Treatment is also substitutive (Levothyroxine). It is used only after thy hypocortisolism has been compensated by glucocorticoids.
Complications
Myxedema coma is the escalation of symptoms of hypothyroidism into a life-threatening condition. The body temperature decreases, the affected person hypoventilates with hypercapnia, so drowsiness manifests itself, which can turn into a comatose state. The victim is also at risk of bradycardia, arrhythmias and heart failure. The cause of these conditions is untreated or poorly treated hypothyroidism when the body is exposed to stress (cold, infection, injury, surgery,...). The diagnosis does not differ from the procedure in peripheral hypothyroidism. Treatment consists of circulatory and respiration (intubation with artificial lung ventilation) control, serving Levothyroxine, glucocorticoids (current adrenal insufficiency cannot be ruled out), preventive ATB and gradual warming.
Euthyroid sick syndrome (ESS)
ESS is a syndrome characterized by changes in thyroid hormones in the clinical manifestation of euthyroidism, which accompanies diseases of other systems.
It occurs in acute and chronic diseases, injuries, after surgeries, conditions of malnutrition, starvation and premature infants.
In the laboratory, we find decreased fT3, normal or decreased fT4 and normal TSH.
ESS is thought to be an adaptive response in the body to minimize catabolism and O2 consumption during stress. After the basic disease has improved, thyroid hormones return to normal. ESS therapy focuses on the basic disease.
